Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. (Q48476082)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 August 2009

Language	Label	Description	Also known as
English	Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.	scientific article published on 25 August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Federica Barbieri

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

author name string

Alessandra Pattarozzi

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Monica Gatti

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Cinzia Aiello

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Ana Quintero

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Gianluigi Lunardi

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Adriana Bajetto

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Angelo Ferrari

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Michael D Culler

9

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Tullio Florio

10

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

publication date

25 August 2009

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

297

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

E1078-88

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Medical therapy for clinically non-functioning pituitary adenomas

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Expression of somatostatin receptor subtypes in human brain tumors.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Influence of somatostatin receptor scintigraphy and CT/MRI on the clinical management of patients with gastrointestinal neuroendocrine tumors: an analysis in 188 patients.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Brain tumor stem cells as research and treatment targets

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Antiangiogenic effect of octreotide inhibits the growth of human rectal neuroendocrine carcinoma

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin analogs in the diagnosis and treatment of cancer

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Growth-arrest-dependent expression and phosphorylation of p27kip at serine10 is mediated by the JNK pathway in C6 glioma cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

G protein activation of a hormone-stimulated phosphatase in human tumor cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin and its receptor family

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Rationale for the use of somatostatin analogs as antitumor agents

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Growing vascular endothelial cells express somatostatin subtype 2 receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Opportunities in somatostatin research: biological, chemical and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Most C6 cells are cancer stem cells: evidence from clonal and population analyses

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Somatostatin receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00292.2009

21 January 2018

Identifiers

10.1152/AJPENDO.00292.2009

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/19706788

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48476082&oldid=823755522"